Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Iridium Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105481677A details a novel iridium-catalyzed route for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN102119165A introduces stable chiral iridium catalysts for asymmetric transfer hydrogenation in water, offering safer and greener pharmaceutical intermediate manufacturing.
Novel aqueous chiral iridium catalyst enables safe, high-yield asymmetric transfer hydrogenation for pharmaceutical intermediates with superior stability.
Patent CN111410604A discloses iridium-phosphine oxazoline catalysis for high-purity chiral intermediates, enabling cost reduction in pharmaceutical manufacturing.
Novel iridium complex enables high-efficiency chiral piperidine synthesis. Reduces steps and enhances supply chain reliability for pharmaceutical intermediates manufacturing globally.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.